/Hologic%2C%20Inc_%20logo%20outside%20building%20by-%20Tada%20Images%20via%20Shutterstock.jpg)
With a market cap of $15.9 billion, Marlborough, Massachusetts-based Hologic, Inc. (HOLX) specializes in developing, manufacturing, and supplying diagnostics, medical imaging systems, and surgical products aimed at advancing women's healthcare. Operating across Diagnostics, Breast Health, GYN Surgical, and Skeletal Health segments, the company provides innovative solutions for early detection and treatment worldwide. The company is set to unveil its fiscal Q1 2025 earnings results after the market closes on Wednesday, Feb. 5.
Ahead of this event, analysts expect the medical device maker to report a profit of $1.01 per share, up 3.1% from $0.98 per share in the year-ago quarter. The company has surpassed Wall Street's bottom-line estimates in three of the past four quarters while missing on another occasion. In the most recent quarter, HOLX missed the consensus EPS estimate by nearly 1% margin.